Professional Documents
Culture Documents
Menorrhagia
WHAT IS IT?
Menorrhagia is excessive menstrual bleeding. It can be described
as menses that lasts longer than 7 days; menses that occurs more
frequently than every 21 days; menses that is heavy enough to
require lifestyle modifications; excessive clotting; or intermen-
strual bleeding.
ETIOLOGY
Common causes of menorrhagia include the following:
Fibroids
Endometriosis
Abortion or threatened miscarriage
Use of some intrauterine devices (IUDs) for birth control
Clinical Pearl
Progesterone-containing IUDs such as the Mirena IUD may decrease
menstrual flow.
157
158 Mosby’s Guide to Women’s Health: A Handbook for Health Professionals
DIAGNOSIS
Careful, comprehensive history
Assessment for iron deficiency anemia
Assessment for reproductive tract cancers
Pelvic examination and Papanicolaou (Pap) smear
Complete blood count (CBC)
Endometrial biopsy
Dilation and curettage (D&C) if the biopsy is normal and
bleeding persists
Ultrasound to evaluate for fibroids and ovarian cysts/tumors
Hysterosalpingogram (HSG)
Hysteroscopy
MANAGEMENT
Identify and manage the causative factor:
Lifestyle
Diet
Foods high in beta-carotene, including watermelon and oth-
er brightly colored fruits and vegetables such as sweet pota-
toes, red yams, peppers, carrots, beets, and squash
Foods high in iron, including fish, poultry, red meats, green
leafy vegetables, and legumes
Spinal Manipulation
Spinal manipulation at the thoracolumbar junction and sacrum.
Anecdotal evidence has reported shorter bleeding times with
adjustment at S2 following cervical cauterization.
23 Menorrhagia 159
Medications
Medications currently used for menorrhagia include the follow-
ing:
Birth control pills help regulate the timing and intensity of
each cycle. Either the combined pill or the progesterone-only
pills may be used. These help maintain a uterine lining that is
less vascular, resulting in lighter periods.
Depo-Provera, the progestin-only birth control injection ad-
ministered every 3 months, reduces the thickness of the endo-
metrial lining, thereby reducing blood loss.
Gonadotropin-releasing hormone (GnRH) agonists such as
Lupron and Nafarelin create a menopausal state by depleting
follicle-stimulating hormone (FSH) and luteinizing hormone
(LH) secretion from the pituitary, thereby reducing or elimi-
nating menstrual flow. GnRH agonists are more commonly
used to minimize blood loss during myomectomy and rarely
are used as a long-term strategy for menorrhagia management.
The nonsteroidal antiinflammatory drugs (NSAIDs) and the
prostaglandin synthetase inhibitors such as Naprosyn, Ibupro-
fen, Advil, and Motrin reduce bleeding and modulate the pain
sometimes associated with menorrhagia.
Antibiotics are administered to treat menorrhagia caused by PID.
PROCEDURES
Endometrial ablation to destroy the entire internal lining of
the uterus
Endometrial resection to remove the lining of the uterus
Insertion of progestin-releasing IUDs, which release small
amounts of levonergesterel locally into the uterus, thereby
reducing menstrual blood loss
Laparoscopy or myomectomy if fibroids or endometriosis are
identified as the causative factor
Hysterectomy or hysterectomy with bilateral salpingo-oopho-
rectomy
Clinical Pearl
The most common complication of menorrhagia is iron deficiency
anemia. Iron is needed by the blood to make hemoglobin, the
160 Mosby’s Guide to Women’s Health: A Handbook for Health Professionals
Clinical Pearl
Menorrhagia in a postmenopausal woman who is not on combined
hormonal replacement therapy is always a cause for concern because of
the risk for vaginal or uterine cancer.